China Molecular Diagnostics Market, Test Volume & Forecast Report 2015

Nov 12, 2015, 12:10 ET from Research and Markets

DUBLIN, Nov. 12, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "China Molecular Diagnostics Market, Test Volume & Forecast" report to their offering.

China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 - 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub-segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.

Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.

This is the 5th report on Molecular Diagnostics industry published by this industry. This report titled China Molecular Diagnostics Market, Test Volume & Forecast provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market.

Key Topics Covered:

1. Executive Summary

2. China Molecular Diagnostic Market & Test Volume Forecast

3. China Molecular Diagnostic Market & Test Volume Share Analysis

4. China Molecular Diagnostic Test Volume - Application Wise (2010 - 2019)

5. China Molecular Diagnostic Market & Forecast - Application Wise (2010 - 2019)

6. Growth Drivers

7. Challenges

8. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets